Cilta-cel in R/R MM: ASCO 2024 Updates from CARTITUDE Trials

Opinion
Video

Hans Lee, MD, discusses recent updates presented at ASCO 2024 surrounding cilta-cel CAR T-cell therapy in relapsed/refractory multiple myeloma.

Recent Videos
5 experts in this video
4 experts in this video
5 experts in this video
4 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
Related Content